Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Caspase-9: structure, mechanisms and clinical application.

Li P, Zhou L, Zhao T, Liu X, Zhang P, Liu Y, Zheng X, Li Q.

Oncotarget. 2017 Apr 4;8(14):23996-24008. doi: 10.18632/oncotarget.15098. Review.

2.

Inflammasomes in Myeloid Cells: Warriors Within.

Jha S, Brickey WJ, Ting JP.

Microbiol Spectr. 2017 Jan;5(1). doi: 10.1128/microbiolspec.MCHD-0049-2016. Review.

3.

DAC can restore expression of NALP1 to suppress tumor growth in colon cancer.

Chen C, Wang B, Sun J, Na H, Chen Z, Zhu Z, Yan L, Ren S, Zuo Y.

Cell Death Dis. 2015 Jan 22;6:e1602. doi: 10.1038/cddis.2014.532.

4.

Anti-proliferative and gene expression actions of resveratrol in breast cancer cells in vitro.

Chin YT, Hsieh MT, Yang SH, Tsai PW, Wang SH, Wang CC, Lee YS, Cheng GY, HuangFu WC, London D, Tang HY, Fu E, Yen Y, Liu LF, Lin HY, Davis PJ.

Oncotarget. 2014 Dec 30;5(24):12891-907.

5.

Current aspects of vitiligo genetics.

Czajkowski R, Męcińska-Jundziłł K.

Postepy Dermatol Alergol. 2014 Aug;31(4):247-55. doi: 10.5114/pdia.2014.43497. Epub 2014 Aug 22. Review.

6.

Genetic analysis of long-lived families reveals novel variants influencing high density-lipoprotein cholesterol.

Feitosa MF, Wojczynski MK, Straka R, Kammerer CM, Lee JH, Kraja AT, Christensen K, Newman AB, Province MA, Borecki IB.

Front Genet. 2014 Jun 3;5:159. doi: 10.3389/fgene.2014.00159. eCollection 2014.

7.

Engineered FADD Induces Apoptosis via an Artificial Death-Inducing Signaling Complex (DISC).

Suzuki E, Takashina T, Nakayama M.

Int J Biomed Sci. 2009 Sep;5(3):237-45.

8.

NLRP1-dependent pyroptosis leads to acute lung injury and morbidity in mice.

Kovarova M, Hesker PR, Jania L, Nguyen M, Snouwaert JN, Xiang Z, Lommatzsch SE, Huang MT, Ting JP, Koller BH.

J Immunol. 2012 Aug 15;189(4):2006-16. doi: 10.4049/jimmunol.1201065. Epub 2012 Jun 29.

9.

Autolytic proteolysis within the function to find domain (FIIND) is required for NLRP1 inflammasome activity.

Finger JN, Lich JD, Dare LC, Cook MN, Brown KK, Duraiswami C, Bertin J, Gough PJ.

J Biol Chem. 2012 Jul 20;287(30):25030-7. doi: 10.1074/jbc.M112.378323. Epub 2012 Jun 4. Erratum in: J Biol Chem. 2012 Sep 7;287(37):31456. Bertin, John J [corrected to Bertin, John].

10.

Computational analysis predicts the Kaposi's sarcoma-associated herpesvirus tegument protein ORF63 to be alpha helical.

Boyle JP, Monie TP.

Proteins. 2012 Aug;80(8):2063-70. doi: 10.1002/prot.24097. Epub 2012 May 17.

11.

Intracellular sensing of microbes and danger signals by the inflammasomes.

Horvath GL, Schrum JE, De Nardo CM, Latz E.

Immunol Rev. 2011 Sep;243(1):119-35. doi: 10.1111/j.1600-065X.2011.01050.x. Review.

12.

Genetic variations in nalp1 mRNA expressions in human vitiligo.

Deo SS, Bhagat AR, Shah RN.

Indian J Dermatol. 2011 May;56(3):266-71. doi: 10.4103/0019-5154.82478.

13.

Discovery of a viral NLR homolog that inhibits the inflammasome.

Gregory SM, Davis BK, West JA, Taxman DJ, Matsuzawa S, Reed JC, Ting JP, Damania B.

Science. 2011 Jan 21;331(6015):330-4. doi: 10.1126/science.1199478. Erratum in: Science. 2011 Sep 23;333(6050):1703.

14.

The inflammasome NLRs in immunity, inflammation, and associated diseases.

Davis BK, Wen H, Ting JP.

Annu Rev Immunol. 2011;29:707-35. doi: 10.1146/annurev-immunol-031210-101405. Review.

15.

Regulation of the Apaf-1-caspase-9 apoptosome.

Bratton SB, Salvesen GS.

J Cell Sci. 2010 Oct 1;123(Pt 19):3209-14. doi: 10.1242/jcs.073643. Review. No abstract available.

16.

Inflammasome-associated nucleotide-binding domain, leucine-rich repeat proteins and inflammatory diseases.

Jha S, Ting JP.

J Immunol. 2009 Dec 15;183(12):7623-9. doi: 10.4049/jimmunol.0902425. Review.

17.

Expression of Nlrp1b inflammasome components in human fibroblasts confers susceptibility to anthrax lethal toxin.

Liao KC, Mogridge J.

Infect Immun. 2009 Oct;77(10):4455-62. doi: 10.1128/IAI.00276-09. Epub 2009 Aug 3.

18.

Regulated cell death pathways: new twists in modulation of BCL2 family function.

Sasi N, Hwang M, Jaboin J, Csiki I, Lu B.

Mol Cancer Ther. 2009 Jun;8(6):1421-9. doi: 10.1158/1535-7163.MCT-08-0895. Epub 2009 Jun 9. Review.

19.

Evaluation of Nod-like receptor (NLR) effector domain interactions.

Wagner RN, Proell M, Kufer TA, Schwarzenbacher R.

PLoS One. 2009;4(4):e4931. doi: 10.1371/journal.pone.0004931. Epub 2009 Apr 1.

20.

Function of Nod-like receptors in microbial recognition and host defense.

Franchi L, Warner N, Viani K, Nuñez G.

Immunol Rev. 2009 Jan;227(1):106-28. doi: 10.1111/j.1600-065X.2008.00734.x. Review.

Supplemental Content

Support Center